These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10612015)

  • 21. Cost-effectiveness of screening for colorectal cancer: a simulation model.
    Neilson AR; Whynes DK
    IMA J Math Appl Med Biol; 1995; 12(3-4):355-67. PubMed ID: 8919570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.
    Sobhani I; Alzahouri K; Ghout I; Charles DJ; Durand-Zaleski I
    Dis Colon Rectum; 2011 Jul; 54(7):876-86. PubMed ID: 21654256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost effectiveness of CT colonography for UK NHS colorectal cancer screening of asymptomatic adults aged 60-69 years.
    Lee D; Muston D; Sweet A; Cunningham C; Slater A; Lock K
    Appl Health Econ Health Policy; 2010; 8(3):141-54. PubMed ID: 20369905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should there be mass screening using faecal occult blood tests for colorectal cancer?
    Faivre J; Tazi MA; Autier P; Bleiberg H
    Eur J Cancer; 1998 May; 34(6):773-80. PubMed ID: 9797686
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost-effectiveness of colorectal cancer screening.
    Donohoe M
    JAMA; 2001 Jan 24-31; 285(4):407; author reply 408. PubMed ID: 11242412
    [No Abstract]   [Full Text] [Related]  

  • 26. [Health economics analysis of colorectal screening].
    Boncz I; Sebestyén A; Dózsa C; Pál M; Sándor J; Palásti J; Betlehem J; Ember I
    Magy Onkol; 2004; 48(2):111-5. PubMed ID: 15351803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cost-effectiveness analysis on colorectal cancer screening program].
    Huang QC; Ye D; Jiang XY; Li QL; Yao KY; Wang JB; Jin MJ; Chen K
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):65-68. PubMed ID: 28100379
    [No Abstract]   [Full Text] [Related]  

  • 28. Estimates of costs and effects of screening for colorectal cancer in the United States.
    Byers T; Gorsky R
    Cancer; 1992 Sep; 70(5 Suppl):1288-95. PubMed ID: 1387342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for colorectal cancer: which test can we afford?
    Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
    [No Abstract]   [Full Text] [Related]  

  • 30. Screening for colorectal cancer: too early to be dogmatic.
    Solomon MJ
    Med J Aust; 1996 Jul; 165(2):68-9. PubMed ID: 8692061
    [No Abstract]   [Full Text] [Related]  

  • 31. Markov's modeling for screening strategies for colorectal cancer.
    Barouni M; Larizadeh MH; Sabermahani A; Ghaderi H
    Asian Pac J Cancer Prev; 2012; 13(10):5125-9. PubMed ID: 23244122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Filtering strategies in mass population screening for colorectal cancer: an economic evaluation.
    Walker A; Whynes DK
    Med Decis Making; 1992; 12(1):2-7. PubMed ID: 1538628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Summaries for patients. Screening for colorectal cancer: recommendations from the United States Preventive Services Task Force.
    Ann Intern Med; 2002 Jul; 137(2):I38. PubMed ID: 12118986
    [No Abstract]   [Full Text] [Related]  

  • 34. Screening and surveillance for colorectal cancer.
    Schnoll-Sussman F; Markowitz AJ; Winawer SJ
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):10-21. PubMed ID: 11049028
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening sigmoidoscopy for colorectal cancer.
    Scholefield JH; Moss S
    Lancet; 2003 Oct; 362(9391):1167-8. PubMed ID: 14568733
    [No Abstract]   [Full Text] [Related]  

  • 36. What's new in colorectal cancer screening?
    Frommer DJ
    J Gastroenterol Hepatol; 1998 May; 13(5):528-33. PubMed ID: 9641653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Screening for colorectal cancer: a cost benefit analysis on a health prevention programme at the Boehringer Ingelheim Company].
    Schneider M; Häck HJ
    Dtsch Med Wochenschr; 2011 May; 136(20):1047-52. PubMed ID: 21560104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening and surveillance for colorectal carcinoma.
    Markowitz AJ; Winawer SJ
    Hematol Oncol Clin North Am; 1997 Aug; 11(4):579-608. PubMed ID: 9257147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention and treatment of colorectal cancer: pay now or pay later.
    Lewis JD
    Ann Intern Med; 2000 Oct; 133(8):647-9. PubMed ID: 11033594
    [No Abstract]   [Full Text] [Related]  

  • 40. Fecal occult blood testing for colorectal cancer. Can we afford not to do this?
    Bond JH
    Gastroenterol Clin North Am; 1997 Mar; 26(1):57-70. PubMed ID: 9119440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.